OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection.

OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection.
复制标题

OX40触发调节性T细胞抑制块并促进肿瘤排斥。

DOI:
10.1084/jem.20071341
复制
发表时间:
2008-04-14
影响因子:
15.3
通讯作者:
Colombo, Mario P.
Colombo, Mario P.
中科院分区:
医学1区
文献类型:
--
作者:
Piconese, Silvia;Valzasina, Barbara;Colombo, Mario P.

文献摘要

参考文献

被引文献

相似文献

调节性T(T reg)细胞是癌症免疫治疗的主要障碍,并且它们的消耗迅速诱导外周前体转化为T reg细胞。我们表明,T reg细胞可以通过OX 40触发功能失活。在肿瘤中,绝大多数CD 4 + T细胞是Foxp 3+和OX 40 bright。然而,肿瘤内注射激动剂抗OX 40单克隆抗体(mAb)OX 86,而不是抗CD 25 mAb,在80%的小鼠中诱导肿瘤排斥反应,这种作用被CD 8耗竭所消除。在肿瘤内OX 40触发后,增加数量的浸润树突状细胞(DC)迁移到引流淋巴结并产生新一波肿瘤特异性细胞毒性T淋巴细胞,如通过淋巴结CD 8 + T淋巴细胞的四聚体和CD 44染色所检测到的。用OX 40缺陷型T reg细胞和野生型(WT)效应T细胞或相互组合重建的荷瘤Rag 1敲除(KO)小鼠表明,T reg和效应T细胞必须通过OX 40触发肿瘤被排斥。因此,接受肿瘤内共注射OX 86和卵清蛋白蛋白的WT而不是OX 40-KO小鼠能够逆转过继转移的OX 40感受态OTII T淋巴细胞的肿瘤诱导的耐受化。总之,OX 40介导的T reg细胞功能失活释放附近的DC,使它们能够诱导适应性免疫应答。此外,已知的适应性信号向活化的T细胞的0X 40依赖性递送通过同时的T reg细胞抑制而增强。因此,0X 40触发具有汇聚以介导肿瘤排斥的多种效应。
Regulatory T (T reg) cells are the major obstacle to cancer immunotherapy, and their depletion promptly induces conversion of peripheral precursors into T reg cells. We show that T reg cells can be functionally inactivated by OX40 triggering. In tumors, the vast majority of CD4+ T cells are Foxp3+ and OX40bright. However, intratumor injection of the agonist anti-OX40 monoclonal antibody (mAb) OX86, but not anti-CD25 mAb, induces tumor rejection in 80% of mice, an effect that is abrogated by CD8 depletion. Upon intratumor OX40 triggering, increased numbers of infiltrating dendritic cells (DCs) migrate to draining lymph nodes and generate a new wave of tumor-specific cytotoxic T lymphocytes, as detected by tetramer and CD44 staining of node CD8+ T lymphocytes. Tumor-bearing Rag1-knockout (KO) mice reconstituted with OX40-deficient T reg cells and wild-type (WT) effector T cells, or the reciprocal combination, showed that both T reg and effector T cells must be triggered via OX40 for the tumor to be rejected. Accordingly, WT but not OX40-KO mice receiving intratumor coinjection of OX86 and ovalbumin protein were able to revert tumor-induced tolerization of adoptively transferred OX40-competent OTII T lymphocytes. In conclusion, OX40-mediated inactivation of T reg cell function unleashes nearby DCs, allowing them to induce an adaptive immune response. In addition, the known OX40-dependent delivery of fitness signals to activated T cells is boosted by concurrent T reg cell inhibition. OX40 triggering thus has multiple effects that converge to mediate tumor rejection.
DOI: 10.1158/0008-5472.can-05-1319
发表时间: 2005-09-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Dercamp, C;Chemin, K;Vicari, AP
通讯作者: Vicari, AP
DOI: 10.1158/0008-5472.can-05-2813
发表时间: 2006-05-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Cohen, AD;Diab, A;Houghton, AN
通讯作者: Houghton, AN
DOI: 10.4049/jimmunol.165.6.3043
发表时间: 2000-09-15
影响因子: 4.4
作者:
Gramaglia, I;Jember, A;Croft, M
通讯作者: Croft, M
用激动性抗GITR mAb治疗晚期肿瘤及其对肿瘤浸润Foxp3+CD25+CD4+调节T细胞的影响。
DOI: 10.1084/jem.20050940
发表时间: 2005-10-03
影响因子: 15.3
作者:
Ko, K;Yamazaki, S;Nakamura, K;Nishioka, T;Hirota, K;Yamaguchi, T;Shimizu, J;Nomura, T;Chiba, T;Sakaguchi, S
通讯作者: Sakaguchi, S
DOI: 10.1016/s0092-8674(00)80059-8
发表时间: 1999-10-01
期刊: CELL
影响因子: 64.5
作者:
Förster, R;Schubel, A;Lipp, M
通讯作者: Lipp, M